Company / Operating Income
Danaher Corporation Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$4.7B
FY2025
5-year range
$3.3B / $6.4B
FY2021-FY2025
Trend
-3.6%
vs FY2024
Sector context
#8 of 156
Health Care
What the data says
Among 156 Health Care companies, Danaher Corporation is in the top 5% for operating income. Operating Income has fluctuated over the past 10 years, ranging from $2.6B in FY2017 to $6.4B in FY2023.
Based on SEC 10-K filings.
$4.7B in FY2025 with a 5-year CAGR of +9.0%. Top quartile in the Health Care sector.
Declined from $6.4B to $4.7B over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- +3.5%
- 5-Year CAGR
- +9.0%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 156This company $4.7B Sector average $733.1M
▼
+539.8% above sector average
Key checks
Key Insights
- 5-year CAGR of +9.0%, indicating consistent growth.
- In FY2025, operating income decreased 3.6% year-over-year.
- Ranks #8 out of 156 companies in the Health Care sector.
- Peak operating income was recorded in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.7B | -3.6% |
| FY2024 | $4.9B | -23.7% |
| FY2023 | $6.4B | +50.7% |
| FY2022 | $4.2B | +29.4% |
| FY2021 | $3.3B | +7.0% |
| FY2020 | $3.1B | -6.5% |
| FY2019 | $3.3B | +7.0% |
| FY2018 | $3.1B | +18.8% |
| FY2017 | $2.6B | -6.0% |
| FY2016 | $2.7B | +26.5% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026